Delivery Order SPE2DB20D2104-SPE2DB25FMPQP

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $47K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $37,904.33, is for the delivery of the medication TREMFYA 100 MG/ML INJECTORML. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,275.81 Firm Fixed Price Delivery Order contract is for the supply of the pharmaceutical product TREMFYA 100 MG/ML INJECTORML. The contract has an ultimate completion date of April 22, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,027.20, is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty medication. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TREMFYA 100 MG/ML INJECTORML. The contract has a ceiling value of $18,547.25 and is a firm fixed-price delivery order with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,812.11, is for the delivery of TREMFYA 100 MG/ML INJECTOR ML medical products. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 28, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,684.82, is for the delivery of TREMFYA 100 MG/ML INJECTORML, a medication. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2025. There is no set-aside designation for this contract. AmerisourceBergen holds a significant...
This is a $8,493.51 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of TREMFYA 100 MG/ML INJECTORML. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,807.09 delivery order contract is for the provision of the prescription medication TREMFYA 100 MG/ML INJECTORML. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $95,467.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML INJECTORML, a medical product, with a completion date of June 11, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,837.51 firm fixed-price delivery order is for the supply of TREMFYA 100 MG/ML INJECTOR, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMPQP
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,735.26, is for the delivery of the medication TREMFYA 100 MG/ML INJECTORML. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 12:59 AM